Recent Comments

Comment RSS

Pulmonary Embolism News and Research RSS Feed - Pulmonary Embolism News and Research

A pulmonary embolism is a sudden blockage in a lung artery. The cause is usually a blood clot in the leg called a deep vein thrombosis that breaks loose and travels through the bloodstream to the lung. Pulmonary embolism is a serious condition that can cause

  • Permanent damage to the affected lung

  • Low oxygen levels in your blood

  • Damage to other organs in your body from not getting enough oxygen


If a clot is large, or if there are many clots, pulmonary embolism can cause death. Half the people who have pulmonary embolism have no symptoms. If you do have symptoms, they can include shortness of breath, chest pain or coughing up blood. Symptoms of a blood clot include warmth, swelling, pain, tenderness and redness of the leg. The goal of treatment is to break up clots and help keep other clots from forming.

Hospitals should expand quality control guidelines to improve surgical complications in older patients

17. November 2009 02:00
The elderly are more vulnerable to problems after a major surgical procedure than younger patients, but a team of investigators using data from the American College of Surgeons National Surgical Quality Improvement Program (ACS NSQIP) suggest that one way to improve surgical results in this age group is to have hospitals expand their quality control guidelines to include more types of surgery-related complications. [More]

Posted in: Healthcare News

Tags: , , , ,

An overview of clinically relevant topics in diagnostic imaging

12. November 2009 04:10
Research and Markets (http://www.researchandmarkets.com/research/6bbc91/imaging_review_bo) has announced the addition of the "Imaging Review: Body, Bone & Breast" report to their offering. [More]

Catheter-directed therapy: First-line treatment option for massive pulmonary embolism

12. November 2009 02:05
Catheter-directed therapy or catheter-directed thrombolysis-an interventional radiology treatment that uses targeted image-guided drug delivery with specially designed catheters to dissolve dangerous blood clots in the lungs-saves lives and should be considered a first-line treatment option for massive pulmonary embolism, note researchers in the November Journal of Vascular and Interventional Radiology. [More]

Anemia-reducing medications linked to deep vein thrombosis in cancer patients

11. November 2009 00:39
Medications frequently given to cancer patients to reduce their risk of anemia are associated with an increased risk of deep vein thrombosis or pulmonary embolism, according to new research led by Dawn Hershman, M.D, M.S., co-director of the breast cancer program at the Herbert Irving Comprehensive Cancer Center at NewYork-Presbyterian Hospital/Columbia University Medical Center. The findings will be published online on Nov. 10, 2009 in the Journal of the National Cancer Institute (ahead of the Dec. 2, 2009 print edition). [More]

Microbix Biosystems receives Health Canada's marketing and export approval for KINLYTIC

11. November 2009 00:28
Microbix Biosystems Inc. today announced that KINLYTIC (urokinase for injection) has been approved in Canada for marketing and export. Health Canada's issuance of a Drug Identification Number for KINLYTIC gives Microbix the opportunity to market the product in Canada and export the clot-busting therapy to markets worldwide. [More]

Posted in: Pharmaceutical News

Tags: , , , , , , , , ,

Angiotech Pharmaceuticals reports financial results for the third quarter ended September 30, 2009

9. November 2009 08:09
Angiotech Pharmaceuticals, Inc. today announced its financial results for the third quarter ended September 30, 2009. [More]

Report on the management of a hospitalized patient

29. October 2009 08:04
Research and Markets (http://www.researchandmarkets.com/research/7b97d7/ucsfs_management) has announced the addition of the "UCSF's Management of the Hospitalized Patient" training to their offering. [More]

Posted in: Healthcare News

Tags: , , , , , , , , ,

Routine use of HRT increases longevity in postmenopausal women

29. October 2009 03:46
Hormone replacement therapy (HRT) to treat menopausal estrogen deficiency has been in widespread use for over 60 years. Several observational studies over the years showed that HRT use by younger postmenopausal women was associated with a significant reduction in total mortality; available evidence supported the routine use of HRT to increase longevity in postmenopausal women. [More]

Catheter-directed therapy safe and effective for treating acute pulmonary embolism

28. October 2009 06:40
William Kuo, MD, was the on-call interventional radiologist one Friday night three years ago when he received a call from the intensive care unit at Stanford Hospital & Clinics. He was asked to attend to a 62-year-old woman who had collapsed at home and was rushed to the emergency room with massive blood clots in her lungs. [More]

Recruitment of Phase II trial of TB-402 completed ahead of schedule

28. October 2009 03:36
ThromboGenics NV and co-development partner BioInvent International announce that they have completed recruitment of their Phase II trial of TB-402 ahead of schedule. [More]

Pulmo BioTech signs agreement with Biotechnology Consulting Poland for commercialization of PulmoBind

24. October 2009 02:28
Pulmo BioTech Inc. has announced that it will ultimately receive at least $3.3 million pursuant to the license agreement contemplated by the previously announced non-binding letter of intent with Biotechnology Consulting Poland Sp. z.o.o. with respect to its Pulmonary Vascular Diagnostic Product Candidate PulmoBind(TM) development work, clinical trials and ultimately, commercialization in the European market. [More]

Updated data on XL184 study in patients with glioblastoma multiforme presented

24. October 2009 01:01
Exelixis, Inc. and Bristol-Myers Squibb Company today reported updated phase 2 clinical data which show that XL184 demonstrated activity in patients with glioblastoma multiforme (GBM), the most common and aggressive form of brain cancer. [More]

Advisory Committee on Immunization Practices supports the permissive use of GARDASIL

22. October 2009 05:17
Merck & Co., Inc. announced today that the U.S. Centers for Disease Control and Prevention’s (CDC’s) Advisory Committee on Immunization Practices (ACIP) supports the permissive use of GARDASIL® [Human Papillomavirus Quadrivalent (Types 6, 11, 16 and 18) Vaccine, Recombinant] for boys and young men ages 9 to 26, which means that GARDASIL may be given to males ages 9 to 26 to reduce the likelihood of acquiring genital warts at the discretion of the patient's health care provider. [More]

Crux Biomedical receives U.S. patent for its novel vena cava filter

22. October 2009 00:31
Crux Biomedical Inc. announced today that it was awarded a U.S. patent, (US 7,582,100 B2), for its novel vena cava filter. [More]

Posted in: Device / Technology News | Medical Patent News

Tags: , , , ,

Study finds lung scintigraphy more reliable than CTA for pulmonary embolism diagnosis in pregnant patients

21. October 2009 03:02
A medical imaging procedure known as lung scintigraphy may be more reliable than pulmonary CT angiography (CTA) for identifying or excluding pulmonary embolism (PE) in pregnant patients, according to a study published in the November issue of the American Journal of Roentgenology. [More]

Posted in: Device / Technology News | Medical Procedure News | Women's Health News

Tags: , , ,

News-Medical.Net provides this medical information service in accordance with these terms and conditions. Please note that medical information found on this website is designed to support, not to replace the relationship between patient and physician/doctor and the medical advice they may provide.